April 28, 2021
The American College of Cardiology (ACC) and HealthReveal announce our collaboration to speed the adoption of clinical guidelines and optimize patient outcomes. Through the ACC’s groundbreaking TRANSFORM program, three first-of-a-kind studies will apply implementation science to revolutionize chronic care.
February 26, 2021
HealthReveal makes the 2021 NYC Digital 100! We are thrilled to be selected as one of NYC’s leading digital health companies. See the full list of incredible innovators + more in the 2021 New York Healthcare Innovation Report.
February 1, 2021
HealthReveal President & Co-Founder, Lori Evans Bernstein, joins LSX Leaders panel discussion on “Optimising Real-World Evidence and Real-World Data” with Novartis’s Adrian Cassidy, Aetion’s Carolyn Magill, Verily’s Vindell Washington, Evidation Health’s Mikki Nasch, and Ford Huntman Media’s Rachel Ford Huntman.
October 14, 2020
HealthReveal’s partnership with Boston Scientific featured at the 2020 TCT Connect event. Simplify and guide the clinical decision-making process using HealthReveal, a clinical AI solution to identify and recommend optimal care for patients based on guidelines.
October 14, 2020
Clover Health announces partnership with Walmart Health, bringing HealthReveal’s data-driven clinical recommendations to help Georgia seniors live better healthier lives.
October 6, 2020
Congratulations to HealthReveal client Clover Health on their IPO announcement!
September 24, 2020
HealthReveal proudly partners with the American College of Cardiology, Novartis, and Dr. Jim Januzzi of Massachusetts General Hospital on optimizing heart failure medication management through the TRANSFORM HFrEF study.
July 14, 2020
HealthReveal Founder & CEO Lonny Reisman co-hosts American College of Cardiology “Working Well” webinar with Barbara Wachsman. Key leaders from MGH, Progressive, IBM, Cigna, and United Healthcare comment on virtual care in the COVID-19 era and the future of fee-for-service.
June 1, 2020
HealthReveal Founder & CEO Lonny Reisman featured in the Journal of American Cardiology in his article “Breaking the Mold: Designing Health Plans That Do Not Impede Delivery of High-Value Care.”
May 13, 2020
HealthReveal President & Co-Founder Lori Evans Bernstein quoted in Crain’s coverage of promising startups in the COVID pandemic: “If we don’t make an impact now, when will we ever?”
April 3, 2020
HealthReveal featured in Oxeon Partners and Bessemer Venture Partners’ podcast A Healthy Dose. Co-founders, Lonny Reisman and Lori Bernstein, discuss the work they are doing with patient risk stratification to play their part in the COVID-19 pandemic.
February 19, 2020
HealthReveal makes the 2020 NYC Digital 100! It’s an honor to be selected as one of NYC’s leading digital health companies.
October 31, 2019
HealthReveal Founder & CEO, Dr. Lonny Reisman, teams up with Comcast’s Shawn Leavitt, Accolade’s Mike Hilton, and Manatt’s Lisa Suennen for HLTH panel session on “Tapping Into Clinical AI for Personalized Care.”
October 29, 2019
Clinical AI Company HealthReveal Expands Executive Team to Fuel Growth.
October 22, 2019
HealthReveal COO, Joshua Tauber, joins a panel discussion on regulatory and reimbursement strategies in the current and rapidly emerging market at the 2019 Deerfield CEO Conference.
October 10, 2019
HealthReveal named UCSF Digital Health Awards Finalist in the category Best Application of AI!
September 19, 2019
HealthReveal CCO, Mina Egan, presents at Plug and Play Cleveland’s 2019 Innovation Day on Clinical AI for personalized chronic care.
July 30, 2019
Recognized as one of America’s foremost healthcare leaders, Karen Ignagni – CEO of EmblemHealth – shares her perspective in Forbes for the future of healthcare and how HealthReveal is working with Emblem to realize that vision.
May 8, 2019
HealthReveal’s CEO, Dr. Lonny Reisman, summarizes in MedCityNews the critical steps needed to accelerate AI-powered clinical care, and improve patient outcomes. When it comes to clinical AI, we must learn to “walk before we run.”
April 22, 2019
Google and its sister companies at Alphabet are investing heavily at the intersection of health and AI. HealthReveal’s CEO, Dr. Lonny Reisman, weighs in on NPR on the complexity of this challenging space, and the delicate balancing act Google faces.
March 28, 2019
EmblemHealth and AdvantageCare Physicians (ACPNY) have partnered with HealthReveal to integrate a groundbreaking clinical AI solution into their Epic EHR. Learn more in Healthcare IT News about how “Reveals” provide the clinical guidance that support each patient’s optimal, personalized care.
March 28, 2019
EmblemHealth and AdvantageCare Physicians (ACPNY) have joined forces with HealthReveal to proactively “Reveal” precise recommendations that improve patient outcomes, embedded in Epic workflow.
December 6, 2018
Hear from HealthReveal’s Dr. Lonny Reisman about the new imperative for cardiovascular care: continually applying guideline-directed medical therapy (GDMT) to patient data to drive improved health outcomes.
November 12, 2018
HealthReveal’s CEO, Dr. Lonny Reisman, summarizes his letter to the editor of Circulation, elaborating on the top three reasons chronically-ill participants often fail to receive guideline-directed medical therapy (GDMT), and the role clinical AI can play to address these challenges.
July 31, 2018
One of healthcare technology’s leading experts, Dr. Lonny Reisman, writes in Managed Healthcare Executive showing plans on how to assemble the missing pieces to preempt costly downstream consequences for chronically ill patients.
February 7, 2018
With half of the US population suffering from one or more chronic conditions, HealthReveal’s Founder and CEO Dr. Lonny Reisman outlines his plan in Becker’s Hospital Review to democratize care country-wide with coordinated medical technology and accurate, real-time patient data.
HealthReveal’s CEO, Dr. Lonny Reisman, shares his view in Accountable Care News on the challenges value-based care faces – and why an orientation toward high quality care for the chronically ill will achieve even greater clinical and financial outcomes.